CME Group: Rates, Volatility, and Macro Hedging

• The Effective Fed Funds Rate, currently at 3.64% and on a falling trend, suggests the peak of the rate-hiking cycle is likely behind us. However, it remains significantly above its historical average of 2.03%, maintaining an environment of higher borrowing costs that impacts financial asset valuations and hedging strategies.
• The 10-Year Treasury, at 4.15%, also exhibits a falling trend, but its level is still in the 82nd percentile historically, reflecting sticky long-term yields. This dynamic, especially when contrasted with the stable 2-Year Treasury at 3.57%, creates an active yield curve environment, often a catalyst for increased hedging activity in futures markets.
• Robust Real GDP growth of 4.40% (79th percentile) signals underlying economic strength, providing a stable backdrop for financial markets even as interest rate expectations adjust. This fundamental strength can support underlying asset values, which in turn drives demand for risk management products.

For CME Group, an exchange operator, this environment presents both opportunities and challenges. While the transition in interest rate expectations and ongoing market volatility typically drives hedging volumes and interest income on collateral, CME's revenue growth has decelerated to +0.4%, and operating margins have contracted to 61.8%. Despite this, the company has delivered strong free cash flow growth of +11.1% and a robust +20.7% rolling 12-month stock return, suggesting resilience and ongoing profitability from diverse trading activity even as the macro landscape shifts.

CME

CME Group is a nuanced macro play: a clear beneficiary of higher interest rates, yet surprisingly sensitive to the pace and stability of economic growth.

CME Group's revenue growth exhibits a strong positive correlation with the *level* of interest rates (β=0.273, 100% stable), a hallmark for an exchange operator that earns significant interest income on segregated client funds. However, it displays a notable inverse relationship with economic expansion: revenue growth is hurt by both high GDP levels (β=-0.168, 83% stable) and rising GDP (β=-0.174, 100% stable). This suggests CME often thrives when market participants are actively hedging or seeking alpha amidst moderate growth or uncertainty, rather than during periods of robust, stable expansion.

As only one company is under review, a direct comparative insight is not applicable. However, CME's unique macro fingerprint highlights its distinct positioning within the financial infrastructure sector.

Investors should view CME Group as a 'rates play' that thrives in higher interest rate environments, providing a valuable hedge against declining bond prices. However, its inverse relationship with robust GDP growth and negative sensitivity to rising inflation warrant careful consideration, suggesting it may perform best in moderately volatile, non-inflationary environments where active risk management and hedging are paramount.

We analyze stock returns around macroeconomic announcements using bootstrap confidence intervals for the median. This approach is robust to outliers and makes no distributional assumptions.

Across the analyzed events, Non-Farm Payrolls and GDP announcements have consistently elicited positive market reactions, while FOMC and CPI days show more mixed, non-directional responses.

Employment and economic growth indicators appear to be the most consistent drivers of immediate market sentiment, suggesting that robust economic activity generally translates into bullish investor behavior on announcement days. In contrast, monetary policy and inflation data, while crucial, often lead to more ambiguous short-term market movements.

• **Non-Farm Payrolls (NFP)**: NFP announcements have historically been associated with a reliably positive market reaction, showing a median daily return of +0.1714% (95% CI: +0.0811% to +0.4279%). The confidence interval explicitly excludes zero, indicating a statistically significant upward bias on these days, with 60.14% of NFP events resulting in positive returns.
• **Gross Domestic Product (GDP)**: GDP releases exhibit the strongest and most reliable positive response, with a median daily return of +0.4377% (95% CI: +0.1162% to +0.6636%). This robust positive reaction, with 62.41% of events showing gains, underscores the market's tendency to reward strong economic growth signals.
• **FOMC and CPI**: Both Federal Open Market Committee (FOMC) announcements and Consumer Price Index (CPI) releases show no statistically reliable directional pattern. FOMC days registered a median return of -0.0754% (95% CI: -0.3541% to +0.1987%), while CPI days saw a median of -0.0208% (95% CI: -0.8053% to +0.3126%). In both cases, the confidence intervals include zero, indicating mixed market reactions where roughly half the events resulted in positive returns (45.05% for FOMC, 50.0% for CPI) and half in negative.

For investors in CME Group Inc., strong macroeconomic indicators like NFP and GDP releases have historically provided a reliable tailwind, suggesting that positive economic surprises tend to be rewarded. While FOMC and CPI announcements are pivotal for financial markets, their immediate impact on CME's stock has been less predictable, underscoring the complex interplay of factors driving an exchange operator's value. Investors should consider these macroeconomic sensitivities when assessing CME's performance, recognizing that economic vitality directly fuels its core business.

As of February 1, 2026, we find ourselves in an 'Easing' rate regime, with the Fed Funds rate at 3.64%, having declined by 0.69% over the past six months. Inflation is 'Moderate' at 2.40% CPI YoY, while the economy is in a robust 'Expansion' with 4.4% GDP growth. Consumer sentiment, however, remains 'Pessimistic' at 52.9. This confluence of conditions places us firmly in an 'Early Expansion' phase of the business cycle.

CME

CME Group thrives in environments of moderate inflation and early cycle expansion, benefiting from stable or easing rate policies.

CME Group, a global derivatives marketplace, exhibits clear macro sensitivities. Historically, it performs best in 'Stable' rate regimes, delivering an average monthly return of +1.67%, with a robust 55.2% of months showing positive returns. Performance remains strong in 'Easing' rate environments, averaging +1.62%/mo, even boasting a higher positive month rate at 69.2%. In stark contrast, 'Tightening' rate regimes see its average monthly return drop to +0.99%, indicating a preference for predictable or declining rate paths rather than rapidly rising ones. The company's sensitivity to inflation is even more pronounced: it shines in 'Moderate' inflation regimes, averaging an impressive +2.49%/mo, but struggles significantly in 'High Inflation' environments, where it posts a negative average monthly return of -0.07%.

The current 'Early Expansion' phase of the business cycle is a significant tailwind for CME Group. Historically, CME has delivered its strongest quarterly returns during this phase, averaging an impressive +9.2% per quarter. This performance is nearly double the +4.5%/qtr seen in 'Mid Expansion' and dramatically outperforms the +0.2%/qtr in 'Contraction' phases, underscoring its cyclical upside.

CME Group stands out as a company with a distinct macro fingerprint, particularly sensitive to inflation and the business cycle. Its strong performance in moderate inflation and early expansion phases, coupled with favorable returns in stable or easing rate environments, positions it as a 'macro optionality' play. While its overall positive returns across most rate regimes suggest a degree of resilience, the significant spread in inflation performance (-0.07%/mo in High Inflation vs. +2.49%/mo in Moderate) means investors must monitor inflation dynamics closely.

Given CME's strong alignment with the current 'Easing' rate and 'Moderate' inflation regimes, coupled with being in its historically best 'Early Expansion' cycle phase, the outlook remains positive if these conditions persist. However, a significant re-acceleration of inflation into 'High Inflation' territory would pose a substantial risk, potentially eroding its strong performance. Conversely, a prolonged 'Easing' cycle, particularly if it stimulates further market activity, could continue to benefit CME's trading volumes and interest income on segregated funds.

For institutional investors, CME Group represents a compelling opportunity in the current macro backdrop, leveraging its historical outperformance in early expansion cycles and moderate inflation. Its sensitivity to inflation regimes suggests that a core position could be complemented by hedging strategies against a resurgence of high inflation. The current environment appears highly conducive to CME's business model, making it a key beneficiary of the present macro narrative.

CME

CME exhibits a positive rate sensitivity of +0.27, starkly contrasting with its peer average of -0.00, indicating it benefits from rising rates where peers are largely neutral.

CME stands out with a moderate positive rate sensitivity of +0.27, meaning its fundamentals strengthen as interest rates climb. This is a significant divergence from the peer average sensitivity of -0.00. Furthermore, CME demonstrates a remarkably low equity Beta of 0.26, substantially below the peer average of 1.33, signaling a much lower correlation to broad market movements. Its GDP sensitivity of -0.17 is also notable, suggesting a moderate inverse relationship with economic growth, unlike the peer average of +0.00.

CME carves out a distinct macro profile within the financial services sector, characterized by its beneficial exposure to rising interest rates and markedly lower systematic market risk. While many peers face headwinds from rate hikes or are more tied to cyclical GDP growth, CME's operational structure positions it to potentially outperform in such environments, offering investors a differentiated blend of defensive characteristics and rate upside.

CME

CME Group stands out as a strong leading indicator across key macro variables, with its fundamentals moving 3 to 6 quarters *before* changes in rates, inflation, GDP, and unemployment.

CME's business activity is a potent harbinger of economic shifts. Its fundamentals anticipate interest rate and CPI changes by a substantial six quarters (β=-0.35 for rates, β=-0.55 for CPI), with the CPI impact showing moderate persistence (half-life of 4Q). Even more acutely, CME's fundamentals move three quarters ahead of GDP shifts (β=-0.65), though this effect is quite transient (half-life of 1Q). Interestingly, CME's fundamentals strengthen six quarters before unemployment rises (β=+0.55), indicating it thrives in anticipation of labor market weakness.

While most companies exhibit a lagging response to macroeconomic changes, CME Group presents a rare and powerful exception, consistently acting as a leading indicator. Its ability to anticipate macro shifts by several quarters sets it apart, offering a distinct advantage in forward-looking market analysis.

Despite being categorized as 'Late-cycle' in its general economic sensitivity, CME's strong leading indicator status implies its activity often anticipates the onset or conclusion of these late-cycle dynamics, rather than merely reacting within them. It signals shifts before the broader economy enters or exits specific cyclical phases.

CME

CME Group Inc. presents a highly unusual stress profile, with revenue growth actually benefiting by +1.31pp under a Severe Stress (2008-like) scenario, while experiencing its most significant downside of -0.46pp under a Rate Shock (2022-like) scenario.

CME Group Inc. stands out with its highly contrarian stress profile, uniquely positioned to potentially benefit from severe market downturns characterized by falling rates and disinflation. This contrasts sharply with many companies that typically experience significant revenue contraction under such conditions. However, its negative sensitivity to rising inflation and rapid rate hikes highlights a distinct set of vulnerabilities that investors must consider.

CME Group demonstrates a moderate overall macro sensitivity, yet is positioned favorably within the current easing rate regime. Despite challenges in deriving stable statistical relationships (as indicated by 0 companies with reliable estimates for scenarios and regressions), the qualitative assessment points to high stress resilience, with even a Severe Stress (2008-like) scenario estimated to yield a +1.31pp increase in revenue growth, suggesting a robust business model even in downturns.

1. CME is favorably positioned in the current easing rate and moderate inflation regime.
2. The company exhibits high stress resilience, with a +1.31pp revenue growth in severe stress scenarios.
3. Falling mortgage rates are a key strength, while rising rates pose the primary macro risk.
4. Investors should acknowledge limitations in quantitative estimates for sensitivity and scenario impacts due to model instability.
5. Monitor interest rate trajectory and market volatility for trading signals.